[StemCyte-KY] Announcement of Board Acting as AGM to Waive Non-Compete Restrictions for New Directors at Subsidiary Taiwan StemCyte
NQ Score
47/100
N1 Content Completeness
10
Key facts
- [StemCyte-KY] Announcement of Board Acting as AGM to Waive Non-Compete Restrictions for New Directors at Subsidiary Taiwan StemCyte
- StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, acted on behalf of the AGM to waive non-compete restrictions for directors Lu Kung-Ming, Kuo Hui-Yuan, and Chen Jui-Ching, allowing them to hold positions in affiliated biotech investment firms.
- Source: TWSE
- Date: Fri May 29 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, acted on behalf of the AGM to waive non-compete restrictions for directors Lu Kung-Ming, Kuo Hui-Yuan, and Chen Jui-Ching, allowing them to hold positions in affiliated biotech investment firms.
- Citation
- [StemCyte-KY] Announcement of Board Acting as AGM to Waive Non-Compete Restrictions for New Directors at Subsidiary Taiwan StemCyte (Fri May 29 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Fri May 29 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, acted on behalf of the AGM to waive non-compete restrictions for directors Lu Kung-Ming, Kuo Hui-Yuan, and Chen Jui-Ching, allowing them to hold positions in affiliated biotech investment firms.
AI Analysis
Frequently Asked Questions
- Q: What is non-compete restriction?
- A: A rule preventing directors from engaging in businesses that compete with their company.
- Q: What are the key facts in this article?
- A: StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, acted on behalf of the AGM to waive non-compete restrictions for directors Lu Kung-Ming, Kuo Hui-Yuan, and Chen Jui-Ching, allowing them to hold positions in affiliated biotech investment firms.
- Q: What is the direct answer?
- A: StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, acted on behalf of the AGM to waive non-compete restrictions for directors Lu Kung-Ming, Kuo Hui-Yuan, and Chen Jui-Ching, allowing them to hold positions in affiliated biotech investment firms.